Category Archives: Emerging Markets

US Regulators and Industry Bodies Push Forward with Global Expansion

At the annual meeting of the Food and Drug Law Institute (FDLI) this year, FDA commissioner Margaret Hamburg concluded her keynote address by describing a “dramatically changing global marketplace” and its “huge implications” for FDA’s ability to ensure the safety and quality of products manufactured elsewhere. In addition to conducting more inspections and oversight of […]
Also posted in Europe, FDA, Global, Regulatory | Tagged , , , , , , | Leave a comment

Investment in Pharma Sales “Flat” in 2013

Industry investment in pharma sales force and marketing channels remained “flat” in 2013 at just under €85 billion constant US dollars, according to newly released data from Cegedim Strategic Data (CSD).
Also posted in Europe, Global, Marketing, Sales, Strategy | Tagged , , , | Leave a comment

Vietnam's Pharma Market "to Rocket" Over Next Six Years

Vietnam’s pharma market in Vietnam is set to increase by $5 billion over the next six years, reaching a net worth of $8 billion by 2020 and representing a Compound Annual Growth Rate (CAGR) of 15.4%, says research firm GlobalData. The company’s  report states that the scarcity of low-priced generic drugs, combined with a belief […]
Also posted in Global | Tagged , , , | Leave a comment

BRIC Nations' "Blossoming Healthcare Budgets" Revive Clinical Trials Opportunities

While some clinical trial sponsors have been driven out of the BRIC nations, a rise in rank for each country — Brazil, Russia, India, China — is expected over the next four years, indicating “blossoming healthcare budgets and markets that are ripe with opportunities for development”. According to a Thomson Reuters report, Overcoming Clinical Challenges in BRIC […]
Also posted in Europe, Global, R&D | Tagged , , , | Leave a comment

Turkey to See Renewed Multinational Investment, Says Report

Turkey is remains a key destination for foreign investment, and the next five years should see renewed interest from pharma multinationals, says a new report by CPhI Worldwide. Although the Turkish government’s price referencing system and fixed euro-lira conversion rate have presented a major obstacle for pharma growth, the report states that these pricing challenges […]
Also posted in Europe, Global, Manufacturing, pricing, R&D | Tagged , , | Leave a comment
  • Categories

  • Meta